Skip to main content

Advertisement

Log in

Recent Trends for Colorectal Cancer Screening in HIV-Infected Patients

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We planned to investigate the recent trends for colorectal cancer (CRC) screening in human immunodeficiency virus (HIV) as compared to non-HIV by interviewing consecutive patients in outpatient clinics during September 2007. Out of a total of 300 patients interviewed, 205 met the inclusion criteria. One hundred and fourteen were HIV-infected, while 91 were non-HIV. HIV received more office visits per year. Despite the high incidence of adenomas on screening colonoscopy, HIV patients were less likely to undergo any type of CRC screening test. A higher number (≥10) of annual clinic visits and the presence of co-morbid conditions were associated with being up-to-date for CRC screening in HIV patients. Conclusion CRC screening is underutilized in HIV patients. Multiple office visits per year are associated with being up-to-date for CRC screening. Hence, increasing patients’ compliance with office visits and educating them about the importance of CRC screening may indirectly increase compliance with CRC screening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860.

    Article  PubMed  Google Scholar 

  2. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620–626.

    PubMed  Google Scholar 

  3. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135:17–26.

    CAS  PubMed  Google Scholar 

  4. Porter K, Babiker A, Bhaskaran K, et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003;362:1267–1274.

    Article  PubMed  Google Scholar 

  5. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22–29.

    Article  CAS  PubMed  Google Scholar 

  6. Wood E, Low-Beer S, Bartholomew K, et al. Modern antiretroviral therapy improves life expectancy of gay and bisexual males in Vancouver’s West End. Can J Public Health. 2000;91:125–128.

    CAS  PubMed  Google Scholar 

  7. Manfredi R. HIV disease and advanced age: an increasing therapeutic challenge. Drugs Aging. 2002;19:647–669.

    Article  CAS  PubMed  Google Scholar 

  8. Lai D, Hardy RJ. An update on the impact of HIV/AIDS on life expectancy in the United States. AIDS. 2004;18:1732–1734.

    Article  PubMed  Google Scholar 

  9. Keiser O, Taffé P, Zwahlen M, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18:1835–1843.

    Article  PubMed  Google Scholar 

  10. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29.

    Article  PubMed  Google Scholar 

  11. HIV Epidemiology Program. New York City Department of Health and Mental Hygiene. Home page at: http://www.nyc.gov/html/doh/html/dires/hivepi.shtml.

  12. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132–141.

    PubMed  Google Scholar 

  13. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004;54:41–52.

    Article  PubMed  Google Scholar 

  14. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–560.

    Article  PubMed  Google Scholar 

  15. Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868–877.

    CAS  PubMed  Google Scholar 

  16. American Society for Gastrointestinal Endoscopy. Guidelines for colorectal cancer screening and surveillance. Gastrointest Endosc. 2000;51:777–782.

    Article  Google Scholar 

  17. Reinhold JP, Moon M, Tenner CT, et al. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2005;100(8):1805–1812.

    Article  PubMed  Google Scholar 

  18. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–1575.

    Article  CAS  PubMed  Google Scholar 

  19. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:96–104.

    PubMed  Google Scholar 

  20. Cooksley CD, Hwang LY, Waller DK, et al. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS. 1999;10:795–802.

    Article  CAS  PubMed  Google Scholar 

  21. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989–2002. Clin Infect Dis. 2004;39:1380–1384.

    Article  PubMed  Google Scholar 

  22. Yegüez JF, Martinez SA, Sands DR, et al. Colorectal malignancies in HIV-positive patients. Am Surg. 2003;69:981–987.

    PubMed  Google Scholar 

  23. Bini EJ, Park J, Francois F. Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch Intern Med. 2006;166(15):1626–1631.

    Article  PubMed  Google Scholar 

  24. Chiao EY, Krown SE. Update on non-acquired immunodeficiency syndrome-defining malignancies. Curr Opin Oncol. 2003;15:389–397.

    Article  PubMed  Google Scholar 

  25. Cappell MS, Yao F, Cho KC. Colonic adenocarcinoma associated with the acquired immune deficiency syndrome. Cancer. 1988;62:616–619.

    Article  CAS  PubMed  Google Scholar 

  26. Klugman AD, Schaffner J. Colon adenocarcinoma in HIV infection: a case report and review. Am J Gastroenterol. 1994;89:254–256.

    CAS  PubMed  Google Scholar 

  27. Demopoulos BP, Vamvakas E, Ehrlich JE, et al. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med. 2003;127:589–592.

    PubMed  Google Scholar 

  28. Wasserberg N, Nunoo-Mensah JW, Gonzalez-Ruiz C, et al. Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis. 2007;22(10):1217–1221.

    Article  PubMed  Google Scholar 

  29. Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006;21(6):661–665.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We especially thank Dr. Marlyn Martinaar, Dr. Vilma Vas, and Dr. Eric A Jaffe for their help and support during the project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahzad Iqbal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iqbal, S., Browne-McDonald, V. & Cerulli, M.A. Recent Trends for Colorectal Cancer Screening in HIV-Infected Patients. Dig Dis Sci 55, 761–766 (2010). https://doi.org/10.1007/s10620-009-0774-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0774-8

Keywords

Navigation